XBiotech Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio26.6418.3910.41
P/B Ratio0.660.560.441.261.31
Price/Tangible Book0.660.560.441.261.31
Price/FCF5.13
Price/OCF4.87
Enterprise Value Ratios
EV/Revenue5.414.99
EV/FCF1.51
Profitability & Returns
Return on Equity (ROE)-0.19%-0.11%-0.13%-0.06%-0.02%
Return on Assets (ROA)-0.12%-0.10%-0.08%-0.05%-0.02%
Return on Invested Capital (ROIC)-1.74%-1.80%-1.25%-0.35%-0.24%
Return on Capital Employed (ROCE)-0.23%-0.17%-0.14%-0.09%-0.05%
Leverage & Solvency Ratios
Debt/Equity0.06
Liquidity Ratios
Current Ratio11.5633.0754.0771.4981.80
Quick Ratio11.4932.9453.9271.2262.26
Efficiency Ratios
Asset Turnover0.010.060.07
Yield & Distribution Ratios
Earnings Yield-0.32%-0.20%-0.31%-0.05%-0.02%
FCF Yield-0.27%-0.16%-0.14%0.19%-0.15%
Buyback Yield0.00%0.00%-0.01%0.03%0.33%